Everest Management Corp’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Everest Management Corp's LLY Position: Q2 2026 in Review
Everest Management Corp reduced its Eli Lilly (LLY) stake by 24% in Q2 2026, selling an estimated $169K and leaving 511 shares worth $613K. The position accounts for 0.23% of the portfolio, ranked #45.
Everest Management Corp first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $622K in Q1 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Everest Management Corp held 511 shares of Eli Lilly worth $613K as of Q2 2026.
- Everest Management Corp sold 165 Eli Lilly shares in Q2 2026, an estimated $169K.
- Eli Lilly made up 0.23% of Everest Management Corp's portfolio in Q2 2026, its #45 holding.
- Everest Management Corp first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
- Everest Management Corp's Eli Lilly position peaked at $622K in Q1 2026.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Everest Management Corp's 13F filing for Q2 2026, filed 7 Aug 2026.